483
Ferring Pharmaceuticals IncFDA 483 - Ferring Pharmaceuticals Inc - March 14, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Ferring Pharmaceuticals Inc. in Parsippany, NJ, identified a significant issue regarding the monitoring of clinical studies. The firm failed to ensure proper oversight of investigational product storage, specifically noting unreported temperature deviations. This indicates a lapse in critical study monitoring practices.
Open in Dashboard
ID · 048ba5ff-1130-486c-b9fc-17cc22a70b5a